Levonorgestrel-based EC (Plan B)

Highlighting one notable research article from each Research Roundup in 2023.

Answers for providers to the most frequently asked questions about repeated EC doses.

Pain management during procedural abortion, serum etonogestrel levels not associated with mood changes during implant use, and clinical considerations when patients are traveling for abortion care.

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

What providers need to know about the December 2022 updates to levonorgestrel emergency contraception (LNG-EC) labeling.

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Perceived pain and sedation dosing during abortion procedures by demographics, PAPP-A as a novel screening for gestational age before medication abortion, patient experiences with progestin-only pills and attitudes towards OTC access.